Inflammatory Markers and Risk for Cognitive Decline in Chronic Kidney Disease: The CRIC Study

Abstract

IntroductionChronic kidney disease (CKD) is associated with an increased risk of cognitive decline, but the mechanisms remain poorly defined. We sought to determine the relation between serum inflammatory markers and risk of cognitive decline among adults with CKD.MethodsWe studied 757 adults aged ≥55 years with CKD participating in the Chronic Renal Insufficiency Cohort Cognitive study. We measured interleukin (IL)−1β, IL-1 receptor antagonist, IL-6, tumor necrosis factor (TNF)−α, high-sensitivity C-reactive protein (hs-CRP), and fibrinogen in baseline plasma samples. We assessed cognitive function at regular intervals in 4 domains and defined incident impairment as a follow-up score more than 1 SD poorer than the group mean.ResultsThe mean age of the sample was 64.3 ± 5.6 years, and the mean follow-up was 6.2 ± 2.5 years. At baseline, higher levels of each inflammatory marker were associated with poorer age-adjusted performance. In analyses adjusted for baseline cognition, demographics, comorbid conditions, and kidney function, participants in the highest tertile of hs-CRP, the highest tertile of fibrinogen, and the highest tertile of IL-1β had an increased risk of impairment in attention compared to participants in the lowest tertile of each marker. Participants in the highest versus lowest tertile of TNF-α had a lower adjusted risk of impairment in executive function. There was no association between other inflammatory markers and change in cognitive function.DiscussionAmong adults with CKD, higher levels of hs-CRP, fibrinogen, and IL-1β were associated with a higher risk of impairment in attention. Higher levels of TNF-α were associated with a lower risk of impaired executive function.

Novel Features and Abnormal Pattern of Cerebral Glucose Metabolism in Spinocerebellar Ataxia 19

“…Reasonably, significant comorbidity contributed to the faster rate of motor progression and low MoCA score in the oldest patient (III:1) in the Swedish SCA19/22 family. Both T2DM and kidney failure are well-known risk factors for cognitive decline and dementia [ 40 , 41 ]. Differently to the described Japanese SCA19/22 patient harboring the T377M mutation in KCND3 , we found polyneuropathy in two patients from the Swedish family who were also affected by T2DM.…”

Does inflammation affect outcomes in dialysis patients?

“…Elevated systemic markers of inflammation are independently associated with cognitive decline in the general population; however, results are not consistent across all studies . Limited available evidence also suggests an association of inflammation with diminished cognitive function in CKD and chronic dialysis patients . In chronic hemodialysis patients, IL‐6 and TNF‐α inversely correlate with the cognitive function subscale of the Kidney Disease Quality of Life questionnaire, suggesting a link between inflammation and cognitive impairment .…”

“…CRP levels are also independently associated with cognitive performance on the mini‐mental state examination before and after a hemodialysis session . Recently, in the Chronic Renal Insufficiency Cohort (CRIC) study, higher CRP, IL‐1β, and fibrinogen levels were associated with increased risk of impaired attention during the approximately 6 year follow‐up period in individuals with baseline CKD …”

Cognitive impairment in patients with moderate to severe chronic kidney disease: the Salford kidney cohort study

“…The diagnosis of cognitive impairment is typically made using absolute validated numerical cut-off scores in brief cognitive screening assessments [ 10–13 ]. The diagnosis can also be made using a relative score that is significantly lower than the rest of the studied population [ 5 , 14–16 ]. A second element of our study aimed to determine a difference in cardiovascular and psychosocial risk factor profiles according to the method of diagnosis used.…”